Cargando…
In Utero Cell Treatment of Hemophilia A Mice via Human Amniotic Fluid Mesenchymal Stromal Cell Engraftment
Hemophilia is a genetic disorder linked to the sex chromosomes, resulting in impaired blood clotting due to insufficient intrinsic coagulation factors. There are approximately one million individuals worldwide with hemophilia, with hemophilia A being the most prevalent form. The current treatment fo...
Autores principales: | Kao, Yung-Tsung, Yen, Chih-Ching, Fan, Hueng-Chuen, Chen, Jen-Kun, Chen, Ming-Shan, Lan, Ying-Wei, Yang, Shang-Hsun, Chen, Chuan-Mu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10670993/ https://www.ncbi.nlm.nih.gov/pubmed/38003601 http://dx.doi.org/10.3390/ijms242216411 |
Ejemplares similares
-
Novel Coagulation Factor VIII Gene Therapy in a Mouse Model of Hemophilia A by Lipid-Coated Fe(3)O(4) Nanoparticles
por: Kao, Yung-Tsung, et al.
Publicado: (2021) -
In Utero Transplantation of Expanded Autologous Amniotic Fluid Stem Cells Results in Long‐Term Hematopoietic Engraftment
por: Loukogeorgakis, Stavros P., et al.
Publicado: (2019) -
Long-Term Hematopoietic Engraftment of Congenic Amniotic Fluid Stem Cells After in Utero Intraperitoneal Transplantation to Immune Competent Mice
por: Shangaris, Panicos, et al.
Publicado: (2018) -
In Utero Transplantation of Placenta-Derived Mesenchymal Stromal Cells for Potential Fetal Treatment of Hemophilia A
por: Kumar, Priyadarsini, et al.
Publicado: (2018) -
Amniotic fluid as a source of engraftable stem cells
por: Borlongan, Cesar V.
Publicado: (2017)